SC 13G

Company

NRX Pharmaceuticals, Inc.

Filed

February 13, 2019

Accession Number

0001062993-19-000754

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →